PCMA Business Forum 2023
“Our experts support life sciences companies, health plans, and their customers as they navigate IRA policy implementation, from Part D redesign to understanding stakeholder behavioral changes.”
PCMA Business Forum
Our experts will be available to discuss these priority topics
Inflation Reduction Act (IRA) Implementation
Inflation-based rebates, Medicare price negotiation, Part D benefit design, and other IRA policies will have a profound impact on healthcare stakeholders. Avalere can help evaluate these policies’ effects and develop strategies for product development and investment decisions, manufacturer contracting strategies, plan formulary and benefit design, and ensuring patient access to medications.
Rethinking Value
The IRA is amplifying the focus on the value of medication, increasing the need for all healthcare stakeholders to consider innovative approaches to evidence generation and the measurement of value. Our experts can share policy, payer, and life sciences perspectives to provide insights on how anticipated market changes will drive behavioral changes across key stakeholders as they make decisions to maintain their business.
Maximizing Payer Engagement
Top-tier payer engagement is built upon an intimate knowledge of payer incentives and decision making and an understanding of how to add value in addition to a contracting strategy. Avalere’s team can help with using data and analytics to maximize formulary negotiations, net pricing, and contracting outcomes, and demystifying the role of actuarial science in plan decision making and the implications for plan negotiations.
Meet Our
Experts
Practice Director,
Market Access & Reimbursement
Expertise: Commercialization strategy, policy, access, reimbursement, net pricing, execution, specialty pharmacy, patient access strategy and services
Managing Director,
Market Access & Reimbursement
Expertise: Real-world evidence, non-traditional evidence generation, strategy, research, operations, technology innovation
Senior Vice President,
Healthcare Transformation
Expertise: Market access and payer strategy, development, execution
Managing Director,
Policy
Expertise: Medicare policy and payment, IRA, oncology, value policy and ICER, state drug pricing
Principal, Policy
Expertise: Medicare policy and payment, IRA, obesity, CMS engagement and advocacy
Consultant II,
Market Access & Reimbursement
Expertise: Health economics, specialty pharmacy and channel, innovative pricing and contracting
Related Insights
We anticipate and identify today’s challenges, opportunities, and top trends to watch.
